Home | NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer has 11 revisions.
RevisionStatus
Saved 22/12/2016 - 11:39am by CIM
current revision (published)
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:37am by CIM
archived
Saved 22/12/2016 - 11:36am by CIM
archived
Saved 22/12/2016 - 11:36am by CIM
archived
Saved 22/12/2016 - 11:36am by CIM
archived
Saved 12/10/2016 - 5:08pm by Gladys
archived